Program

DAY ONEDAY TWO

TUESDAY OCTOBER 6th 2015

8.00

Registration and networking breakfast

9.00
CHAIR'S WELCOME

muellerDr Michael C. Müller
Managing Partner
Cepton Strategies/CRA

 INNOVATION MANAGEMENT IN HEALTHCARE 

INNOVATION SOURCING

9.15 OPENING KEYNOTE

Disruptive times: What will healthcare innovation look like in 2025?

  • Demand will continue to outstrip supply in healthcare
  • Changing patterns of disease and the challenges these bring
  • If we can’t know the future, what can we be certain of?

Prof David Haslam, Chair, National Institute for Health and Care Excellence (NICE)

 

9.45 KEYNOTE

Managing innovation in healthcare
Chris Moore, Life Sciences EMEIA Lead Partner, EMEIA Advisory, EY

 

10.15 BEST PRACTICE & WEBCAST

Creating an innovation culture: The Florida Hospital Innovation Lab & Princeton Warehouse
Stefan W. Herzberg, Co-Founder and
Dr Karen Tilstra, Co-Founder, Florida Hospital Innovation Lab – FHIL

 

10.45 VISION

Smart research: Implementing patient self-reported outcome tools at the FDA
Dr Mark Wolff, Principal Industry Consultant Health & Life Sciences Global Practice, SAS Institute

 

11.15

NETWORKING BREAK

 BUSINESS MODEL INNOVATION  

THE NEXT GENERATION R&D COLLABORATION

11.45

New entrants on the horizon: How pharma and biotech can work together in new paradigms
Dr Werner Lanthaler, CEO, Evotec

 

12.15

Molecular diagnostics and targeted cancer treatments – Towards a unified approach by pharma and academia
Dr Gerd Maass, Head of Strategic Partnerships, Roche Pharma

 

12.45

Approaches to foster collaborations in early drug discovery
Prof Stefan Jaroch, Head External Innovation Technologies, Global External Innovation & Alliances, Bayer Pharma

 

13.15

LUNCH

OPEN INNOVATION

14.15

Project Data Sphere: Sharing information and making data transparent in oncology trials
Dr Martin J. Murphy, CEO, CEO Roundtable on Cancer

 

14.45

Connecting patients and clinical research: How can we improve the patient experience?
Robert Kroes, Project Lead Clinical Open Innovation Europe, Eli Lilly

 

15.15

Health issues on the web: Social, service, search
Lara Kobilke, Research Assistant, Munich Digital Institute

 

15.45

NETWORKING BREAK

 

16.15

New form of alliance: How big data supports disease management, population health and drug development
Nitzan Sneh, CEO, CliniWorks

 

CAPTURING ALL COMMER CIALISATION AND MAR KETING CHANNE LS BY PARTNERING

16.45

New ways of drug application and patient monitoring: How technology improves therapy outcomes
Dr Alexander Schachinger, CEO, EPatient RSD

 

17.15

CHAIR’S CLOSING REMARKS AND END OF DAY ONE
Dr Michael C. Müller

 

GET-TOGETHER EVENING EVENT

WEDNESDAY, OCTOBER 7th 2015

8.30

Welcome with coffee and tea

 

9.00
CHAIR'S WELCOME

Gerd W. StürzGerd W. Stürz
Market Segment Leader Life Sciences, Healthcare and Chemicals, Germany, Switzerland and Austria
EY

MHEALTH: MULTIPLYING INNOVATION BY TECHNOLOGY

9.15

Digital health: Patient services, health literacy and adherence
Eddie Chan, Global Head Search & Evaluation, Sanofi

 

9.45

Patient engagement and beyond
Peter Aksel Villadsen, Senior Director Global Patient Engagement, LEO Pharma

 

10.15

mHealth – Nice to have or the next brilliant coup in healthcare?
Dr Urs C.H. Wiedemann, VP, Cepton Strategies/CRA

 

11.00

NETWORKING BREAK

 REGULATIONS IN HEALTHCARE INNOVATION 
11.30 KEYNOTE

Challenges in healthcare innovation – Facts and future
Dr Stephan Brock, Chief Technology Officer, Molecular Health

 

12.00 PANEL DISCUSSION

Mistrust, data restriction, difficulties in valuation – What are the main barriers that are still hindering ground-breaking ideas in healthcare?

Martha Carruthers, Global Marketing Director, Janssen Healthcare Innovation
Dr Jan Hille, Director Strategy, Business Development and M&A, Siemens Healthcare
Dr Hans Hofstraat, VP, Innovation Manager and Member of the HealthTech Programme Board, Philips Research
Dr Volker Möckel, Senior Global Trial Leader, Novartis

Moderated by Jürgen Peukert, Partner, EY

 

12.45
ROUNDTABLE SESSION – SHARE YOUR EXPERIENCES AND GET NEW INSIGHTS

ROUNDTABLE 1: Innovation sourcing – Is the future of healthcare collaborative?

What are the best ways and strategies to get fresh ideas for your future business? How can innovation be stimulated? Do players have to collaborate with IT companies and further new market entrants to succeed?
Moderated by Dr Michael C. Müller


ROUNDTABLE 2: Gamification – Applied Interactive Technologies to engage customers in the health ecosystem

Technology turned out to be one of the most important factors influencing healthcare nowadays. How might we get patients involved by using it?
Moderated by Jürgen Peukert


ROUNDTABLE 3: Innovation barriers

How might we overstep regulative hurdles and challenges to boost innovation?

Moderated by Dr Stephan Brock

 

13.30

PRESENTATION OF THE ROUNDTABLE RESULTS

 

13.45

CHAIR’S FIVE TAKE-AWAYS
Gerd W. Stürz

14.00 – 15.00

FLYING LUNCH AND END OF THE SUMMIT